Procter & Gamble Health share news, announcements and annual reports

NSE: PGHLBSE: 500126Pharmaceuticals & BiotechnologySmall Cap

Procter & Gamble Health Limited · Formerly Merck · Face value ₹10 · Listed Jan 1982 on BSE, Apr 1996 on NSE

₹5,670.50₹157.00 (2.85%)BSE ₹5,684.40

Share price at the NSE close on 30 Oct 2026. Previous close ₹5,513.50.

30 Oct: open ₹5,501.50, high ₹5,731.00, low ₹5,442.50

52-week range of traded prices to 30 Oct 2026

₹4,707.00Low, 6 Apr 2026₹6,975.00High, 15 Jul 2026

Next results date: the board meets on 2 Nov 2026 to consider: financial results. The notice · Results calendar

Market cap: ₹9,413 Cr585th largest listed
P/E: 26.37
P/B: 17.94
Dividend yield: 3.62%
ROE: 67.2%
ROCE: 84.2%
Debt to equity: 0.00
Volume, NSE: 13,61957.6% delivered

Procter & Gamble Health board meetings

113 filed, newest first. Page 1 of 3.

Sep 2026
- 30 Sep · Board meeting
  To consider and approve the financial results for the period ended September 30, 2026
Jun 2026
- 26 Jun · Board meeting
  To consider and approve the financial results for the quarter ended Jun 30, 2026
Mar 2026
- 27 Mar · Board meeting
  To consider and approve the audited financial statements for the financial year ended March 31, 2026, and recommend final dividend, if any.
Dec 2025
- 26 Dec · Board meeting
  To consider and approve the financial results for the period ended December 31, 2025
- 26 Dec · Board meeting
  Board Meeting to be held on 06-Feb-2025 to inter-alia consider and approve the Audited Financial results of the Company for the Quarterly ended December 2025 .
Nov 2025
- 5 Nov · Board meeting
  Board meeting held on November 05, 2025.
Sep 2025
- 29 Sep · Board meeting
  To consider and approve the financial results for the period ended September 30, 2025 and dividend
Aug 2025
- 1 Aug · Board meeting
  Board meeting held on August 01, 2025.
Jun 2025
- 27 Jun · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2025
Mar 2025
- 26 Mar · Board meeting
  To consider and approve the audited financial results for the financial year ended March 31, 2025 and recommend dividend, if any.
Dec 2024
- 27 Dec · Board meeting
  To consider and approve the financial results for the period ended December 31, 2024
Nov 2024
- 4 Nov · Board meeting
  Board meeting held on November 04, 2024.
Sep 2024
- 27 Sep · Board meeting
  To consider and approve the financial results for the period ended September 30, 2024
Aug 2024
- 21 Aug · Board meeting
  Outcome of Board Meeting held on August 21, 2024.
Jun 2024
- 27 Jun · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2024 and dividend (if any)
May 2024
- 2 May · Board meeting
  Board meeting held on May 02, 2024.
- 2 May · Board meeting
  Board meeting held on May 02, 2024.
Mar 2024
- 27 Mar · Board meeting
  We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, May 2,2024, inter alia, to consider and approve Unaudited Financial Results for the Quarter ended March 31, 2024.
Jan 2024
- 12 Jan · Board meeting
  In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, February 6, 2024, inter alia, to consider and approve unaudited Financial Results for the quarter ended December 31, 2023 and to consider declaration of dividend (if any).
Nov 2023
- 3 Nov · Board meeting
  Board meeting held on November 03, 2023.
Sep 2023
- 27 Sep · Board meeting
  To consider and approve the financial results for the period ended September 30, 2023
Jul 2023
- 17 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2023 and dividend (if any)
May 2023
- 15 May · Board meeting
  Board meeting held on May 15, 2023.
Apr 2023
- 24 Apr · Board meeting
  To consider and approve the financial results for the period ended March 31, 2023
Jan 2023
- 9 Jan · Board meeting
  In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, February 8, 2023, inter alia, to consider and approve the unaudited financial results for the quarter ended December 31,2022 and the declaration of interim dividend for the Financial Year 2022-23, if any.
Nov 2022
- 11 Nov · Board meeting
  We are pleased to inform you that at the meeting of the Board of Directors of the Company heldtoday (started at 6:25 p.m. and concluded at 7:15 p.m.), the Unaudited Financial Results for thequarter ended September 30, 2022 were approved.We are enclosing herewith the following:a. Unaudited Financial Results for the quarter ended September 30, 2022;b. Press Release; andc. Limited Review Report in respect of the Unaudited Financial Results for the quarter endedSeptember 30, 2022 furnished by Statutory Auditors of the CompanyKindly take the same on record and oblige.
Oct 2022
- 17 Oct · Board meeting
  With reference to the announcement dated October 7, 2022 and in terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform you that the meeting of the Board of Directors of the Company is now rescheduled to be held on Friday, November 11, 2022, inter alia, to consider and approve the unaudited financial results for the quarter ended September 30, 2022.
- 7 Oct · Board meeting
  In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, November 9, 2022, inter alia, to consider and approve the unaudited financial results for the quarter ended September 30, 2022
  Not held on this date
Aug 2022
- 29 Aug · Board meeting
  We are pleased to inform you that at the meeting of the Board of Directors of the Company held today (commenced at 12.45 pm and ended at 2:55 pm), the Audited Financial Results for Financial Year ended June 30, 2022 were approved. We are enclosing herewith the following: a. Audited Financial Results for the Financial Year ended June 30, 2022, as per format prescribed under Regulation 33 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015; b. Auditor's Report, in respect of the aforementioned Financial Results, as furnished by the Statutory Auditors of the Company; c. Press Release; and d. A declaration with respect to Audit Report with unmodified opinion to the aforementioned Audited Financial Results We are pleased to further inform you that the Board of Directors of the Company at its meeting held today, inter alia, have recommended a final dividend of Rs.11.50 per equity share, for the financial year ended June 30, 2022. The dividend shall be paid between November 28, 2022 to December 18, 2022, on approval of the Members at the 55th Annual General Meeting. Kindly take the same on record.
- 5 Aug · Board meeting
  In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, August 29,2022, inter alia, to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30, 2022 and to consider recommendation of dividend (if any).
May 2022
- 5 May · Board meeting
  We are pleased to inform you that at the meeting of the Board of Directors of the Company held today (commenced at 6:00 p.m. and ended at 7: 20 p.m.), the Unaudited Financial Results for the quarter ended March 31,2022 were approved.We are enclosing herewith the following:a. Unaudited Financial Results for the quarter ended March 31, 2022;b. Press Release; andc. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended March 31, 2022 furnished by Statutory Auditors of the CompanyFurther, we are pleased to inform you that the Board of Directors of the Company at its meeting held today, inter alia, have recommended an Interim Dividend for the Financial Year 2021-22 of Rs. 41 per Equity Share (Face Value of Rs. 10/- each). The dividend shall be paid on or before May 31, 2022. As informed earlier in our letter dated April 28, 2022, record date for the purpose of eligibility for payment of said Interim Dividend shall be May 13,2022.
Mar 2022
- 30 Mar · Board meeting
  Board Meeting to be held on 05-May-2022 to consider and approve the unaudited financial results for the quarter ended March 31, 2022.Kindly take the same on record.
Feb 2022
- 9 Feb · Board meeting
  Board meeting held on February 09, 2022.
Jan 2022
- 17 Jan · Board meeting
  To consider and approve the unaudited financial results for the period ended December 31, 2021
Nov 2021
- 9 Nov · Board meeting
  We are pleased to inform you that at the meeting of the Board of Directors of the Company held today, the Unaudited Financial Results for the quarter ended September 30, 2021 were approved.We are enclosing herewith the following:a. Unaudited Financial Results for the quarter ended September 30, 2021;b. Press Release; andc. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended September 30, 2021 furnished by Statutory Auditors of the CompanyKindly take the same on record and oblige.
Oct 2021
- 8 Oct · Board meeting
  In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, November 9, 2021, inter alia, to consider and approve the unaudited financial results for the quarter ended September 30, 2021.
Aug 2021
- 16 Aug · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2021 and recommend dividend(if any).
May 2021
- 6 May · Board meeting
  Outcome of Board Meeting held on May 06, 2021.
Apr 2021
- 27 Apr · Board meeting
  To consider and approve the financial results for the period ended March 31, 2021
Feb 2021
- 10 Feb · Board meeting
  Board meeting held on February 10, 2021.
Jan 2021
- 12 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2020
Oct 2020
- 23 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2020
Sep 2020
- 15 Sep · Board meeting
  Board meeting held on September 15, 2020.
- 7 Sep · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2020 and dividend
May 2020
- 29 May · Board meeting
  Board meeting held on May 29, 2020.
- 22 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2020
Feb 2020
- 7 Feb · Board meeting
  Board meeting held on February 07, 2020.
Dec 2019
- 31 Dec · Board meeting
  To consider and approve the financial results for the period ended December 31, 2019
Nov 2019
- 7 Nov · Board meeting
  Board meeting held on November 07, 2019.
Oct 2019
- 28 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2019 and declaration of interim dividend, if any.

Procter & Gamble Health board meetings

Sep 2026

Jun 2026

Mar 2026

Dec 2025

Nov 2025

Sep 2025

Aug 2025

Jun 2025

Mar 2025

Dec 2024

Nov 2024

Sep 2024

Aug 2024

Jun 2024

May 2024

Mar 2024

Jan 2024

Nov 2023

Sep 2023

Jul 2023

May 2023

Apr 2023

Jan 2023

Nov 2022

Oct 2022

Aug 2022

May 2022

Mar 2022

Feb 2022

Jan 2022

Nov 2021

Oct 2021

Aug 2021

May 2021

Apr 2021

Feb 2021

Jan 2021

Oct 2020

Sep 2020

May 2020

Feb 2020

Dec 2019

Nov 2019

Oct 2019